Trial Profile
Phase II trial of HX 100 in patients with allergic asthma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs HX 100 (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 16 Apr 2015 New trial record
- 14 Apr 2015 This trial is expected to be initiated in late 2015, according to a Hydra Biosciences media release.